AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Byline: Bruce Japsen
CHICAGO _ Should a deadly bird flu spread quickly around the world, Americans could find themselves at the back of the line for any new vaccine developed to combat it.
There are few U.S. vaccine makers. And even those, such as Deerfield, Ill.-based Baxter International Inc., produce most of their flu vaccine outside the United States in countries that can claim first dibs on any vaccine made to protect against bird flu, the company and government officials admit.
While U.S. health officials and vaccine makers would like to think goodwill would take precedence at the outbreak of a fast-spreading bird flu pandemic, the void in U.S.-based production capacity for vaccines could create a major problem should a vaccine become available.
"If there is an epidemic of bird flu and people start dying in the proportion people believe, I don't think goodwill is going to be an issue," said Dr. Robert Daum, head of the pediatric infectious diseases program at the University of Chicago and former chairman of the Food and Drug Administration's vaccine…
Source: HighBeam Research, U.S. at risk in bird flu pandemic.(Tamiflu, Baxter International Inc.)